Biotalys NV (86C.F)
| Previous Close | 3.0300 |
| Open | 3.0300 |
| Bid | 2.9800 x N/A |
| Ask | 3.1000 x N/A |
| Day's Range | 3.0300 - 3.0300 |
| 52 Week Range | 1.6500 - 6.3400 |
| Volume | |
| Avg. Volume | 35 |
| Market Cap | 99.687M |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireBiotalys Starts Field Trials for Second Biofungicide
Ghent, BELGIUM, May 02, 2024 (GLOBE NEWSWIRE) -- Biotalys (Euronext: BTLS) an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced the initiation of field trials for BioFun-6, the company’s second biofungicide program under development on its AGROBODY technology platform. Kevin Helash, Chief Executive Officer of Biotalys, commented: “Moving BioFun-6 into the field is another important milestone for Biotalys, demonstrating
- GlobeNewswire
Biotalys Appoints Laura J. Meyer to Board of Directors
Agricultural executive with global financial and commercial expertiseGhent, Belgium, April 30, 2024 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced that it has appointed Laura J. Meyer to its Board of Directors and head of the Audit Committee, effective September 25, 2024. Ms. Meyer will replace Ms. Catherine Moukheibir who has decided to step down from the board. Ms.
- GlobeNewswire
Results of the Ordinary and Extraordinary Shareholders’ Meeting
Press release – regulated information Ghent, BELGIUM, April 23, 2024 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, held its ordinary and an extraordinary shareholders' meeting today at 10:00 CEST at the Company’s seat. The legally required presence quorum was reached for the extraordinary shareholders’ meeting. The shareholders approved all items on th
